World Parasitology Market Analysis and Reports | USA Conference Series

Market Analysis - World Parasitology 2017

Parasitic diseases are primarily diseases of poverty. At serious risk are individuals, communities and countries least able to afford the costs of treatment or prevention. In turn, economic development projects which aim to increase income levels may lead to negative results because of increased transmission of parasitic diseases often results.

The global IVD infectious disease market was valued at over US$ 13 billion in 2014 and is expected to grow at a CAGR of 8.2% over the forecast period. Rising prevalence of infectious diseases, growing base of geriatric population, lower immunity levels, and rising awareness among people about communicable diseases are estimated to be high impact rendering drivers.

The global market for infectious disease diagnostic, vaccine and pharmaceutical products was US$  59.2 billion in 2011 and US$ 66.4 billion in 2012.  Market growth looks promising, the overall market value for 2017 is projected to be US$ 96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.

Conference Highlights:

  • Field Parasitology
  • Medical Protozology
  • Medical Helminthology
  • Parasitic Zoonoses
  • Medical Entomology
  • Agriculture and Veterinary Parasitology
  • Experimental Immunoparasitology
  • Structural Parasitology
  • Molecular and Biochemical Parasitology
  • Tropical Diseases
  • Wildlife and Fisheries Parasitology
  • Vector-borne disease
  • Public Health Parasitology
  • Diagnostic Parasitology
  • Parasitic Diseases: Control
  • Ecological and Systematic Parasitology

Parasitic infections affect millions of people every year:

  • More than 300,000 persons living are infected with Trypanosoma cruzi, the cause of Chagas disease.
  • At least 1,000 people are hospitalized with neurocysticercosis every year.
  • Each year at least 70 people, most of them children, are blinded by the parasite that causes Toxocariasis.
  • More than 60 million persons are chronically infected with Toxoplasma gondii.
  • Each year 1.1 million people are newly infected with Trichomonas.

WHO estimates that about 655,000 people die from malaria every year, though a recent systematic analysis suggested the true annual mortality is closer to 1.24 million (Murray et al., 2012). Inexpensive oral drugs—chloroquine and sulfadoxine-pyrimethamine-were once common treatment for malaria, but resistance to these treatments is widespread (WHO, 2012c). Since 2001, the WHO has recommended treating malaria with artemisinin combination therapies (WWARN, 2012c). The use of artemisinin combination drugs as first-line therapy is essential to malaria control. As of 2006, however, there is evidence of artemisinin resistance in Southeast Asia (WWARN, 2012c).

Veterinary parasitology laboratory market:

In 2015, North America dominated the veterinary reference laboratory market followed by Europe, Asia-pacific, and Rest of the World. Increasing demand for animal-derived food products, rising companion animal healthcare expenditure, growing number of veterinary practitioners and their income levels, and rising awareness about zoonotic diseases are factors driving the growth of this market. On the other hand, the Asia-Pacific (APAC) region is expected to witness the highest growth rate during the forecast period. This can be mainly attributed to the growing livestock population, increasing pet adoption, rising awareness about animal health, rising demand of animal derived products, and growing per capita animal health expenditure in this region.

The global veterinary parasitology laboratory market is estimated to grow at a CAGR of 9.8% from 2016 to 2021 to reach USD 2.76 Billion by 2021. Factors such as growing demand for pet insurance and rising animal health expenditure, increasing demand for animal-derived food products, growth in the number of veterinary practitioners and their income levels in developed economies, and increasing incidence of zoonotic diseases are the major factors driving the growth of the global market. 

Hospitals Statistics in USA working on Parasitology

Total Number of All U.S. Registered  Hospitals


Number of U.S. Community Hospitals


Number of Nongovernment Not-for-Profit Community Hospitals


 Number of Investor-Owned (For-Profit)
Community Hospitals


Number of State and Local Government Community Hospitals


Number of Federal Government Hospitals


Number of Nonfederal Psychiatric Hospitals


Number of Nonfederal Long Term Care Hospitals


Number of Hospital Units of Institutions
(Prison Hospitals, College Infirmaries, Etc.)


  Total Staffed Beds in All U.S. Registered * Hospitals


        Staffed Beds in Community** Hospitals


  Total Admissions in All U.S. Registered * Hospitals


        Admissions in Community** Hospitals


  Total Expenses for All U.S. Registered * Hospitals


        Expenses for Community** Hospitals


  Number of Rural Community** Hospitals


  Number of Urban Community** Hospitals


  Number of Community Hospitals in a System ***


  Number of Community Hospitals in a Network ****

























*Registered hospitals are the hospitals that meet AHA's criteria for registration as a hospital facility.

**Communityhospitals are defined as all nonfederal, short-term general, and other special hospitals. Other special hospitals include obstetrics and gynecology; eye, ear, nose, and throat; rehabilitation; orthopedic; and other individually described specialty services. Community hospitals include academic medical centers or other teaching hospitals if they are nonfederal short-term hospitals. Excluded are hospitals not accessible by the general public, such as prison hospitals or college infirmaries.

***System is defined by AHA as either a multihospital or a diversified single hospital system. A multihospital system is two or more hospitals owned, leased, sponsored, or contract managed by a central organization. Single, freestanding hospitals may be categorized as a system by bringing into membership three or more, and at least 25 percent, of their owned or leased non-hospital preacute or postacute health care organizations. System affiliation does not preclude network participation.

**** Network is a group of hospitals, physicians, other providers, insurers and/or community agencies that work together to coordinate and deliver a broad spectrum of services to their community. Network participation does not preclude system affiliation.

Major Worldwide Hospitals Working on Parasitology

  • Young Animal Hospital
  • Mayo Clinic
  • Carter County Animal Hospital
  • Lakewood Animal Hospital
  • Wignall Animal Hospital
  • Crouse Hospital
  • Animal Hospital of Clemons
  • Burnsville Parkway Animal Hospital
  • Oak Knoll Animal Hospital
  • Stiern Southwest Veterinary Hospital
  • Hiltop Animal Hospital
  • The Johns Hopkins Hospital
  • Lehigh Valley Hospital
  • MedStar Washington (D.C.) Hospital Center

Major Parasitology Associations in & around Chicago, USA

  • American Society of Parasitology
  • American Society of Tropical Medicine & Hygiene
  • American Association of Veterinary Parasitologists
  • World Federation of Parasitologists
  • World Association for the Advancement of Veterinary Parasitology
  • No More Malaria
  • Southwestern Association of Parasitology
  • Amercian Society of Animal Science
  • American Public Health Association (APHA)
  • American Board of Pathologists
  • Infectious Diseases Society of America

Major Woldwide Parasitology Associations

  • American Association of Veterinary Parasitology
  • Australian Veterinary Association
  • Association of RoumanianParasitologists
  • British Veterinary Association
  • British Society For Parasitology
  • Chinese Society of Parasitology
  • Danish Society for Parasitology
  • German Society for Parasitology
  • Hungarian Society Parasitologists
  • Irish Society for Parasitology 
  • Japanese Society of Parasitology
  • Japanese Society of Tropical Medicine
  • Korean Society for Parasitology
  • Malaysian Society of Parasitology and Tropical Medicine
  • New England Association of Parasitologists
  • NetVet Veterinary and Animal Science Organizations
  • Parasitological Society of Southern Africa
  • Russian Society of Nematologists
  • Royal Society of Tropical Medicine and Hygiene (RSTMH)
  • Serbian Society of Parasitologists
  • Scandinavian-Baltic Society for Parasitologists
  • Swiss Society of Tropical Medicine and Parasitology
  • The European Scientific Counsel for Companion Animal Parasites
  • The Japanese Society of Parasitology

Major Pharmaceutical Companies/Labs working on Parasitic infections


  • Abbott Laboratories
  • Ariad Pharmaceuticals
  • AstellasPharma US, Inc.
  • Bristol-Myers Squibb
  • Baxter International Worldwide
  • Cubist Pharmaceuticals, Inc.
  • Eli Lilly
  • Merck & Co.
  • Mylan Laboratories
  • Pfizer Inc

World Wide

  • Bayer HealthCare
  • Dainippon Sumitomo Pharma
  • Elder Pharmaceuticals
  • Ego Pharmaceuticals
  • Ferring Pharmaceuticals
  • Fresenius Medical Care
  • GlaxoSmithKline
  • Gilead Sciences
  • Hikma Pharmaceuticals
  • H. Lundbeck
  • Janssen Pharmaceutica
  • Kyowa Hakko
  • Lepetit Pharmaceuticals
  • Panacea Biotec Ltd
  • Sanofi-Aventis
  • Salix Pharmaceuticals
  • Valeant Pharmaceuticals

Market Growth of Parasitic Drugs Manufacturers Worldwide

Universities Associated with Parasitology Research


  • Arizona State University
  • Harvard University
  • Keele University
  • Louisiana State University Health Sciences Center 
  • Michigan State University
  • New York University 
  • Shandong University 
  • The University of Illinois
  • Texas A&M University
  • Tulane University

World Wide

  • Aga Khan University
  • Moscow State University
  • McGill University
  • University of Florida
  • University of Minnesota Worldwide
  • University Copenhagen
  • University Otago
  • University Queensland
  • University Leiden
  • University Melbourne
  • University Alberta
  • University Leeds
  • University Kiel
  • University Leipzig
  • University of Toronto  

Fund Allotment to Parasitology Research


Prevention and Control of Parasitic Diseases

With strong public health programs, political will, financial backing, proper sanitation, mass drug administration and insect control certain human parasitic diseases can be controlled and even eliminated. For eg, in the US mosquito abatement programs after World War II almost eliminated malaria from the country, and hookworm elimination programs in the early 20th century significantly reduced hookworm infections in the South. These efforts had profound effects on the local economy, health and wellbeing. However, for a variety of reasons (political, financial, ecological and biological) it is difficult to control or eliminate certain parasitic pathogens from a region, hence there is need for new cost effective therapies for human parasitic disease.